Regeneron Pharma (REGN) PT Lowered to $787 at RBC Capital
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $840.93 -1.3%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 22
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 22
Join SI Premium – FREE
RBC Capital analyst Kennen MacKay lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $787.00 (from $789.00) while maintaining a Sector Perform rating.
You May Also Be Interested In
- RBC Capital Reiterates Sector Perform Rating on Regeneron Pharma (REGN)
- Rakuten Inc. (4755:JP) (RKUNF) PT Lowered to JPY900 at Nomura/Instinet
- VersaBank (VBNK) PT Lowered to $20 at Raymond James
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
